Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries

BACKGROUND: Managed entry agreements (MEAs) continue to emerge in health technology assessment (HTA)-based decision-making, to address evidentiary uncertainties arising therein. Evidence on the HTA criteria that influence MEAs' uptake remains scarce. This study explores the HTA criteria that de...

Descripción completa

Detalles Bibliográficos
Autor principal: Efthymiadou, Olina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406668/
https://www.ncbi.nlm.nih.gov/pubmed/36219363
http://dx.doi.org/10.1007/s10198-022-01526-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406668/
https://www.ncbi.nlm.nih.gov/pubmed/36219363
http://dx.doi.org/10.1007/s10198-022-01526-x

Ejemplares similares